ADAMTS1 and metabolic dysfunction-associated steatotic liver disease: In accordance with these studies, the decreased levels of ADAMTS1 observed in our analysis from the NAFLD and ATH samples could be related to an abnormal immune response, contributing to the development of both disorders.